Ari Mahrer, data reporter for the San Francisco Business Times, took a look at some of the monumental achievements from companies on their women-led life sciences list. Immune-Onc’s recent milestone: received Orphan Drug Designation for IO-202 for the treatment of chronic myelomonocytic leukemia from the FDA.